Proceedings of the National Academy of Sciences, Volume 123, Issue 15, April 2026. SignificanceCell-free DNA (cfDNA) in blood carries molecular signals from multiple organs, offering a powerful, noninvasive way to detect disease and monitor health. Current cfDNA methylation tests are costly and usually focus on a single condition. We …

Read original article